Renaissance Technologies - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 66 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,650,000
-1.6%
428,700
-13.7%
0.00%
+100.0%
Q2 2018$1,676,000
+2840.4%
496,600
+2253.6%
0.00%
Q2 2016$57,00021,1000.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders